IP Library › Granted Patent US 12,365,655
Granted Patent B2
US 12,365,655 · App. 17/392,356 · Granted Jul 22, 2025

Compounds

Inventors: H. Rachel Lagiakos (Parkville, AU); Richard Charles Foitzik (Parkville, AU); Catherine Fae Hemley (Melbourne, AU); Michelle Ang Camerino (Parkville, AU); Paul Anthony Stupple (Parkville, AU); Ylva Elisabet Bergman Bozikis (Parkville, AU); Scott Raymond Walker (Parkville, AU)
Assignee: CTXT PTY LTD
C07D261/20C07D413/10C07D413/12C07D417/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,365,655
App. No.
17/392,356
Granted
Jul 22, 2025
Kind
B2
Abstract

A compound of formula (I), or a pharmaceutical salt thereof:

Claims (65)

1. A compound of formula (I), or a pharmaceutically acceptable salt thereof:

wherein:

R 1 , R 2 , R 3 and R 4 are independently selected from the group consisting of:

(i) H;

(ii) C 1-3 alkyl, optionally substituted by:

hydroxy,

C 1-2 alkoxy,

NH 2 ,

phenyl,

C 5-6 heteroaryl,

C 1-4 alkyl carbamoyl, or

acylamido;

(iii) C 1-3 alkoxy, optionally substituted by C 3-6 cycloalkyl or by one or more fluoro groups;

(iv) C 3-6 cycloalkyl;

(v) halo;

(vi) COR C , where R C is selected from NR N1 R N2 , where R N1 and R N2 are independently selected from H and methyl;

(vii) cyano, NH 2 , or NO 2 ; and

(viii) phenyl or C 5-6 heteroaryl, optionally substituted by methyl, hydroxy or methoxy; and

Ar is a phenyl, optionally substituted by one or more groups selected from the group consisting of:

(i) C 1-4 alkyl, optionally substituted by hydroxy, C 1-2 alkoxy, NH 2 , C 1-4 alkyl carbamoyl, or by one or more fluoro groups;

(ii) C 3-6 cycloalkyl;

(iii) hydroxy; cyano; NR N3 R N4 , where R N3 and R N4 are independently selected from H and methyl; or acylamido;

(iv) halo;

(v) C 1-3 alkoxy, optionally substituted by hydroxy, C(O)NH 2 , C 3-6 cycloalkyl, phenyl, C 5-6 heteroaryl, or by one or more fluoro groups;

(vi) phenoxy, optionally substituted by fluoro;

(vii) phenyl or C 5-6 heteroaryl; and

(viii) SF 5 or SO 2 CH 3 ;

and wherein at least one of R 1 , R 2 , R 3 and R 4 is not H.

2. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is C 1-3 alkyl, optionally substituted by:

hydroxy,

C 1-2 alkoxy,

NH 2 ,

phenyl,

C 5-6 heteroaryl,

C 1-4 alkyl carbamoyl, or

acylamido.

3. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is C 1-3 alkoxy, optionally substituted by C 3-6 cycloalkyl or one of or more fluoro groups.

4. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is C 3-6 cycloalkyl.

5. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is halo.

6. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is COR C , where R C is selected from NR N1 R N2 , where R N1 and R N2 are independently selected from H and methyl.

7. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is cyano, NH 2 or NO 2 .

8. The compound or salt of claim 1 , wherein at least one of R 1 , R 2 , R 3 and R 4 is phenyl or C 5-6 heteroaryl, optionally substituted by methyl, cyano, hydroxy or methoxy.

9. The compound or salt of claim 1 , wherein:

(a) R 4 is methoxy, R 2 is CH 2 OCH 3 or CH 2 OCH 2 CH 3 , and R 1 and R 3 are H;

(b) R 4 is methoxy, R 2 is phenyl, optionally substituted by methyl or methoxy, and R 1 and R 3 are H;

(c) R 4 is methoxy, R 2 is C 5-6 heteroaryl, optionally substituted by methyl;

(d) R 4 is methoxy and R 1 , R 2 and R 3 are H;

(e) R 4 is chloro, R 2 is C 1-3 alkyl or bromo, and R 1 and R 3 are H;

(f) R 4 is chloro and R 1 , R 2 and R 4 are H; or

(g) R 3 is C 1-3 alkyl and R 1 , R 2 and R 4 are H.

10. The compound or salt of claim 1 , wherein:

(a) Ar is substituted by C 1-4 alkyl, optionally substituted by hydroxy, C 1-2 alkoxy, NH 2 , C 1-4 alkyl carbamoyl, or one or more fluoro groups;

(b) Ar is substituted by C 3-6 cycloalkyl;

(c) Ar is substituted by hydroxy; cyano; NR N3 R N4 , where R N3 and R N4 are independently selected from H and methyl; or acylamido; or

(d) Ar is substituted by halo.

11. The compound or salt of claim 1 , wherein Ar is substituted by C 1-3 alkoxy, optionally substituted by hydroxy, C(O)NH 2 , C 3-6 cycloalkyl, phenyl, C 5-6 heteroaryl, or one or more fluoro groups.

12. The compound or salt of claim 1 , wherein:

(a) Ar is substituted by phenoxy, optionally substituted by fluoro;

(b) Ar is substituted by phenyl or C 5-6 heteroaryl; or

(c) Ar is substituted by SF 5 or SO 2 CH 3 .

13. The compound or salt of claim 1 , wherein Ar is:

(a) 5-ethyl-2-methoxyphenyl;

(b) 5-CF 3 -2-methoxyphenyl; or

(c) 2,6-dimethoxyphenyl.

14. The compound or salt of claim 1 , wherein two of R 1 , R 2 , R 3 and R 4 are H.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: LAGIAKOS, H. RACHEL; MORROW, BENJAMIN JOSEPH; FOITZIK, RICHARD CHARLES; HEMLEY, CATHERINE FAE; CAMERINO, MICHELLE ANG; STUPPLE, PAUL ANTHONY; BOZIKIS, YLVA ELISABET BERGMAN; WALKER, SCOTT RAYMOND
To: MONASH UNIVERSITY
Reel/Frame 057062/0979 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2021
From: MONASH UNIVERSITY
To: CTXT PTY LTD
Reel/Frame 057063/0566 →
Priority Claims (1)
GB 1810092 · Jun 20, 2018 · national
Continuity (2)
Continuation 16446868 · Jun 20, 2019
Related Publication 20220153710A1 · May 19, 2022
References Cited (264)
US 2358031A · Roblin et al. · 1944 [cited by applicant]
US 2525321A · Hultquist et al. · 1950 [cited by applicant]
US 3064003A · Satzinger et al. · 1962 [cited by applicant]
US 3332942A · Breivogel et al. · 1967 [cited by applicant]
US 3951967A · Novello · 1976 [cited by applicant]
US 3960854A · Novello · 1976 [cited by applicant]
US 4172896A · Uno et al. · 1979 [cited by applicant]
US 4251664A · Spitzner · 1981 [cited by applicant]
US 6248767B1 · Blok et al. · 2001 [cited by applicant]
US 9493429B2 · Chen et al. · 2016 [cited by applicant]
US 11492346B2 · Bozikis et al. · 2022 [cited by applicant]
US 20060025415A1 · Gonzalez et al. · 2006 [cited by applicant]
US 20060128706A1 · Bruncko et al. · 2006 [cited by applicant]
US 20060258657A1 · Bruncko et al. · 2006 [cited by applicant]
US 20070015787A1 · Bruncko et al. · 2007 [cited by applicant]
US 20070072860A1 · Bruncko et al. · 2007 [cited by applicant]
US 20090042945A1 · Frank et al. · 2009 [cited by applicant]
US 20090163545A1 · Goldfarb · 2009 [cited by applicant]
US 20120208811A1 · Taka et al. · 2012 [cited by applicant]
US 20130022629A1 · Sharpe et al. · 2013 [cited by applicant]
US 20150183802A1 · Chen et al. · 2015 [cited by applicant]
US 20160009667A1 · Chen et al. · 2016 [cited by applicant]
US 20160376289A1 · Okuyama et al. · 2016 [cited by applicant]
US 20200039945A1 · Lagiakos et al. · 2020 [cited by applicant]
US 20200399258A1 · Bozikis et al. · 2020 [cited by applicant]
BE 617370A · 1962 [cited by applicant]
CA 2121724A1 · 1994 [cited by applicant]
CN 101747325A · 2010 [cited by applicant]
CN 101845043A · 2010 [cited by applicant]
CN 107098846A · 2017 [cited by applicant]
DE 1102745B · 1961 [cited by applicant]
EP 181018A2 · 1986 [cited by applicant]
EP 371438A2 · 1990 [cited by applicant]
EP 0558258A1 · 1993 [cited by applicant]
EP 0569193A1 · 1993 [cited by applicant]
FR 2690160A1 · 1993 [cited by applicant]
GB 689281A · 1953 [cited by applicant]
JP 29002834B · 1927 [cited by applicant]
JP 36003685B · 1936 [cited by applicant]
JP 36019566B · 1936 [cited by applicant]
JP 3901229B · 1939 [cited by applicant]
JP 49008255B · 1974 [cited by applicant]
JP 5452075A · 1979 [cited by applicant]
JP 03258771A · 1991 [cited by applicant]
JP 63238006A · 1998 [cited by applicant]
JP 2003292485A · 2003 [cited by applicant]
PL 220630B1 · 2015 [cited by applicant]
WO 199321171A1 · 1993 [cited by applicant]
WO 199427979A1 · 1994 [cited by applicant]
WO 199631492A1 · 1996 [cited by applicant]
WO 199739000A1 · 1997 [cited by applicant]
WO 199813366A1 · 1998 [cited by applicant]
WO 199821186A1 · 1998 [cited by applicant]
WO 199849162A1 · 1998 [cited by applicant]
WO 2001019798A2 · 2001 [cited by applicant]
WO 200149289A1 · 2001 [cited by applicant]
WO 200164642A2 · 2001 [cited by applicant]
WO 200164643A2 · 2001 [cited by applicant]
WO 2003042700A2 · 2003 [cited by applicant]
WO 2003044000A1 · 2003 [cited by applicant]
WO 2004085385A2 · 2004 [cited by applicant]
WO 2004103980A1 · 2004 [cited by applicant]
WO 2004113310A1 · 2004 [cited by applicant]
WO 2005009967A2 · 2005 [cited by applicant]
WO 2005013914A2 · 2005 [cited by applicant]
WO 2006044405A1 · 2006 [cited by applicant]
WO 2006116614A1 · 2006 [cited by applicant]
WO 2006116615A1 · 2006 [cited by applicant]
WO 2006122799A1 · 2006 [cited by applicant]
WO 2006124744A1 · 2006 [cited by applicant]
WO 2007039174A2 · 2007 [cited by applicant]
WO 2007039175A1 · 2007 [cited by applicant]
WO 2007057093A1 · 2007 [cited by applicant]
WO 2007075895A2 · 2007 [cited by applicant]
WO 2008022286A2 · 2008 [cited by applicant]
WO 2008063668A1 · 2008 [cited by applicant]
WO 2008064116A2 · 2008 [cited by applicant]
WO 2008089307A2 · 2008 [cited by applicant]
WO 2009012242A2 · 2009 [cited by applicant]
WO 2009058348A1 · 2009 [cited by applicant]
WO 2009080223A1 · 2009 [cited by applicant]
WO 201019788A1 · 2010 [cited by applicant]
WO 2010046780A2 · 2010 [cited by applicant]
WO 2010121963A1 · 2010 [cited by applicant]
WO 2011017561A1 · 2011 [cited by applicant]
WO 2011082400A2 · 2011 [cited by applicant]
WO 2011085575A1 · 2011 [cited by applicant]
WO 2011137089A1 · 2011 [cited by applicant]
WO 2011156610A2 · 2011 [cited by applicant]
WO 20120007868A2 · 2012 [cited by applicant]
WO 2012080729A2 · 2012 [cited by applicant]
WO 2012088438A1 · 2012 [cited by applicant]
WO 2012129562A2 · 2012 [cited by applicant]
WO 2014144545A2 · 2014 [cited by applicant]
WO 2015112465A1 · 2015 [cited by applicant]
WO 2016135582A1 · 2016 [cited by applicant]
WO 2016198507A1 · 2016 [cited by applicant]
WO 2017002120A1 · 2017 [cited by applicant]
WO 2017098421A1 · 2017 [cited by applicant]
WO 2018081167A1 · 2018 [cited by applicant]
WO 2018102419A1 · 2018 [cited by applicant]
WO 2018226976A1 · 2018 [cited by applicant]
WO 2019243491A1 · 2019 [cited by applicant]
WO 2020254946A1 · 2020 [cited by applicant]
Neidlein & J. Tauber, Pharmazeutische Zentralhalle, 1968, 107(6), 430-432. [cited by applicant]
Pachhamia J. Indian Chem. Soc., 1988, 65(5), 357-361. [cited by applicant]
Pattan et al., Asian Journal of Research in Chemistry, 2009, 2(2), 123-126. [cited by applicant]
Pattan et al., Iranian Journal of Pharmaceutical Sciences, 2009, 5(4), 225-230. [cited by applicant]
Persa et al., Cancer Letters, 2015 368(2), 252-261 doi:10.1016/j.canlet.2015.03.003. [cited by applicant]
Polozov et al., Tetrahedron Letters, 2010, 51(4), 575-578. [cited by applicant]
Potkin et al., Russian Journal of Organic Chemistry, 2009, 45(6), 879-883. [cited by applicant]
Rosenthal et al., Bioorganic & Medicinal Chemistry Letters, 2013, 23(20), 5660-5666. [cited by applicant]
Savastre et al., Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Veterinary Medicine, 2013, 70(1), 134-139. [cited by applicant]
U.S. Appl. No. 16/446,868 amendment filed Jan. 5, 2021. [cited by applicant]
U.S. Appl. No. 16/902,515 pending claims filed Jun. 16, 2020. [cited by applicant]
Sheikh et al., Blood, 2015, 125(12), 1910-21 doi:10.1182/blood-2014-08-594655. [cited by applicant]
Shi et al., Nature Biotech, 2015, 33, 661-667 doi:10.1038/nbt.3235. [cited by applicant]
Singh et al., International Journal of Chemical Sciences, 2012, 10(3), 1487-1492. [cited by applicant]
Smaine et al., Bioorganic & Medicinal Chemistry Letters, 2008, 18(24), 6332-6335. [cited by applicant]
Spillane et al., Journal of Agricultural and Food Chemistry (2009), 57(12), 5486-5493. [cited by applicant]
Stachel, Chemische Berichte, 1963, 96, 1088-97. [cited by applicant]
Stein et al., Journal of Medicinal Chemistry, 1995, 38, 1344-1354. [cited by applicant]
Stern et al., Crit. Rev. Oncol. Hematol., 2005, 54, 11-29 doi:10.1016/j.critrevonc.2004.10.011. [cited by applicant]
Su et al., Int. J. Mol. Sci., 2016, 17, 1-18 doi:10.3390/ijms17101594. [cited by applicant]
Sugai et al., Chemical & Pharmaceutical Bulletin, 1984, 32(2), 530-7. [cited by applicant]
Suyama et al., Heterocycles, 2003, 60(1), 121-129. [cited by applicant]
Tait et al., Bollettino chimico Farmaceutico, 1990, 129(9), 273-275. [cited by applicant]
Tan et al., Yingyong Huaxue, 2016, 33(9), 1067-1072. [cited by applicant]
Tao, H et al., Lung Cancer, 2012, 75, 95-101 doi:10.1016/j.lungcan.2011.06.002. [cited by applicant]
Thomas et al., Development, 2000, 127, 2537-2548 PMID:10821753. [cited by applicant]
Thomas et al., Genes Dev, 2006, 20(9), 1175. [cited by applicant]
Turner-Ivey et al., Neoplasia, 2014, 16(8): 644-655 doi:10.1016/j.neo.2014.07.007. [cited by applicant]
Valerio et al., Cancer Research, 2017, 77(7), 1753-62 doi:10.1158/0008-5472.CAN-16-2374. [cited by applicant]
Vikani et al., Journal of the Indian Chemical Society, 1990, 67(10), 859-61. [cited by applicant]
Vizmanos et al., Genes Chromosomes Cancer, 2003, 36(4), 402-405 doi:10.1002/gcc.10174. [cited by applicant]
Voss et al., BioEssays, 2009, 31(10), 1050-1061 doi:10.1002/bies.200900051. [cited by applicant]
Wang et al. EBioMedicine, 2016, 13, 99-112 doi:10.1016/j.ebiom.2016.10.018. [cited by applicant]
Wang et al., Gaodeng Xuexiao Huaxue Xuebao, 1987, 8(2), 133-6. [cited by applicant]
Wang et al., Oncogene, 2017, 36, 3048-3058 doi:10.1038/onc.2016.458. [cited by applicant]
Wells et al., Journal of Medicinal Chemistry, 2001, 44(21), 3488-3503. [cited by applicant]
Xiao et al., Cell reports, 2014, 7, 1471-1480 doi :10.1016/j.celrep.2014.04.021. [cited by applicant]
Xiao-Jian et al., Frontiers in Oncology, 2015, 5, 108. [cited by applicant]
Yan et al., Breast Cancer Research, 2011, 13, R47 doi:10.1186/bcr2869. [cited by applicant]
Yoshida et al., Yakugaku Zasshi 1954, 74, 948-50. [cited by applicant]
Young et al., Blood Res 2016 51(3), 152-154 doi:10.5045/br.2016.51.3.152. [cited by applicant]
Zack et al., Nature Genetics 2013 45, 1134-1140 doi:10.1038/ng.2760. [cited by applicant]
Zhang et al., Mini. Rev. Med. Chem., 2017, 17, 1-8 doi:10.2174/1389557516666160923125031. [cited by applicant]
Bruncko et al., database CAPLUS Acc. No. 2007:359148, CAS SciFinder abstract of US 2007/0072860 A1 (Mar. 29, 2007). [cited by applicant]
Dekker et al., Drug, Discov. Today, 2014, 19, 654-660 doi:10.1016/j.drudis.2013.11.012. [cited by applicant]
Dhuban et al., Sci. Immunol., 2017, 2, 9297 doi:10.1126/sciimmunol.aai9297. [cited by applicant]
Doyon et al., Mol. Cell., 2006, 21, 51-64 doi :10.1016/j.molcel.2005.12.007. [cited by applicant]
Duong et al., Cancer Res., 2013, 73, 5556-5568 doi:10.1158/0008-5472.CAN-13-0013. [cited by applicant]
Dzhemukhadze et al., Fenol'nye Soedineniya i Ikh Biologicheskie Funktsii, Materialy Vsesoyuznogo Simpoziuma po Fenol'nym Soedineniyam 1968, 196-202. [cited by applicant]
Fairley et al., Synlett, 2013, 24(5), 570-574. [cited by applicant]
Falk et al., J. Biomolecular Screening 16(10): 2011 DOI:10.1177/1087057111421631. [cited by applicant]
Fan et al., Oncogene, 2015, 1-12. [cited by applicant]
Fernandes et al., Journal of the Institution of Chemists (India), 1991, 63(3), 83-4. [cited by applicant]
Fujita et al., Yakugaku Zasshi, 1964, 84(11), 1061-7. [cited by applicant]
Geng et al.. Nature Immunology, 2 017, (online) doi:10.1038/ni.3748. [cited by applicant]
Ghizzoni et al., Eur. J. Med. Chem., 2012, 47, 337-344 doi:10.1016/j.ejmech.2011.11.001. [cited by applicant]
Gil et al., J. Proteomics, 2017, 150, 297-309 doi :10.1016/j.jprot.2016.10.003. [cited by applicant]
Giri et al., Journal of the Indian Chemical Society, 1964, 41(4), 295-8. [cited by applicant]
Gobert et al., Cancer Research, 2009, 69, 2000-2009 doi:10.1158/0008-5472.CAN-08-2360. [cited by applicant]
Grashey et al., Chemiker-Zeitung 1976, 100(11), 497-8. [cited by applicant]
Grashey et al., Chemiker-Zeitung, 1973, 97(11), 623. [cited by applicant]
Grashey et al., Tetrahedron Letters, 1972, (29), 2943-6. [cited by applicant]
Hangan et al., Farmacia, 2012, 60(6), 932-938. [cited by applicant]
Hangan et al., Journal of Chemical Sciences (Bedin, Germany), 2016, 128(5), 815-824. [cited by applicant]
Hangan et al., Russian Journal of Coordination Chemistry, 2015, 41(6), 395-404. [cited by applicant]
Hassan et al., Journal of Chemical Technology and Biotechnology, 1982, 32(2), 416-20. [cited by applicant]
Hategan et al., Bioorganic & Medicinal Chemistry Letters, 2009, 19(23), 6797-6800. [cited by applicant]
Hirsch et al., J. Mol. Biol., 2017, 429(13), 1958-1977. [cited by applicant]
Hitchin et al., Med. Chem. Common., 2013, 4, 1513-1522. [cited by applicant]
Holbert et al., J. Biol. Chem., 2007, 282, 36603-36613 doi:10.1074/jbc.M705812200. [cited by applicant]
Hultquist et al., Journal of the American Chemical Society, 1951, 73, 2558-66. [cited by applicant]
Iizuka et al, Cancer Sci., 2013, 104, 1647-1655 doi:10.1111/cas.12303. [cited by applicant]
Iizuka et al., Mol. Cell. Biol., 2006, 26, 1098-1108 doi :10.1128/MCB.26.3.1098-1108.2006. [cited by applicant]
International Preliminary Report on Patentability for PCT/EP2019/066337, dated Dec. 22, 2020. [cited by applicant]
International Search Report and Written Opinion for PCT/IB2020/055589, dated Jul. 9, 2020. [cited by applicant]
Joshi et al., Immunity 2015, 43, 579-590 doi:10.1016/j.immuni.2015.08.006. [cited by applicant]
Judes et al., Epigenomics, 2015, 7(8), 1351-1363. [cited by applicant]
Keil et al., ChemMedChem, 2011, 6(4), 633-653. [cited by applicant]
King et al., Journal of Biological Chemistry, 2009, 284(14), 9059-9065. [cited by applicant]
Klosa, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft, 1954, 287, 12-14. [cited by applicant]
Kurihara et al., Yakugaku Zasshi, 1965, 85(10), 920-5. [cited by applicant]
Kuznetsov et al., Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya 1976, (2), 319-22. [cited by applicant]
Lalezar et al., Journal of Heterocyclic Chemistry, 1966, 3(3), 336-7. [cited by applicant]
Lazaris et al., Khimiya Geterotsiklicheskikh Soedinenii, 1973, (10), 1345-50. [cited by applicant]
Lee, Archives of Pharmacal Research, 2004, 27(3), 305-313. [cited by applicant]
Li et al., PNAS, 2007, 104, 4571-4576 doi:10.1073/pnas.0700298104. [cited by applicant]
Liu, Workman and Vignali, The FEBS journal, 2016, 283, 2731-2748. [cited by applicant]
Malev, Metody Polucheniya Khimicheskikh Reaktivov i Preparatov 1964, No. 8, 44-8. [cited by applicant]
Melero et al. Nature Reviews Cancer, 2015, 15, 457-472 doi:10.1038/nrc3973. [cited by applicant]
Meng et al., Zhongguo Yaowu Huaxue Zazhi, 1996, 6(4), 257-261. [cited by applicant]
Merson et al., J. Neurosci., 2006, 26, 11359-11370 doi :10.1523/JNEUROSCI.2247-6.2006. [cited by applicant]
Miller, A.M. et al. J. Immunol., 2006, 177, 7398-7405 doi:10.4049/jimmunol.177.10.7398. [cited by applicant]
Mochona et al., Bioorg. & Med. Chem. Lett., 2016, 26(12), 2847-2851. [cited by applicant]
Neidlein & Hausmann, Zeitschrift fur Naturforschung, Teil B. Chemie, Biochemie, Biophysik, Biologie und wervandte Gebeite, 1966, 21(9), 898. [cited by applicant]
Aggarwal and Calvi, Nature, 2004, 430, 372-376 doi:10.1038/nature02694. [cited by applicant]
Aiello et al., Ricerca Scientifica, Parte 2: Rendiconti, Sezione B: Biologica, 1964, 4(4), 575-80. [cited by applicant]
Avvakumov et al., Oncogene, 2007, 26, 5395-5407 doi:10.1038/sj.onc.1210608. [cited by applicant]
Baell et al., Nature, doi:/10.1038/s41 586-018-0387-5, 2018. [cited by applicant]
Berge et al., J. Pharm. Sci., 1977, 66, 1-19 doi:10.1002/jps.2600660104. [cited by applicant]
Borrow et al., Nat. Genet., 1996, 14, 33-41 doi:10.1038/ng0996-33. [cited by applicant]
Brown et al., Biocehmical Society Transactions, 2016, 44(4), 979-986. [cited by applicant]
CAS Registry No. 1032507-60-0, 2094317-93-6, 891027-49-9, and 891028-05-0. [cited by applicant]
CAS Registry No. 1032507-60-0, entered STN Jul. 3, 2008. [cited by applicant]
CAS Registry No. 1207646-75-0, entered STN Mar. 2, 2010. [cited by applicant]
CAS Registry No. 1207661-17-3, entered STN Mar. 2, 2010. [cited by applicant]
CAS Registry No. 1808493-75-5, entered STN Sep. 29, 2015. [cited by applicant]
CAS registry No. 1808522-80-6, entered STN Sep. 29, 2015. [cited by applicant]
CAS registry No. 1808570-72-0, entered STN Sep. 29, 2015. [cited by applicant]
CAS Registry No. 1808779-04-5, entered STN Sep. 29, 2015. [cited by applicant]
CAS registry No. 1808779-26-1, entered STN Sep. 29, 2015. [cited by applicant]
CAS registry No. 2094188-03-9, entered STN May 2, 2017. [cited by applicant]
CAS registry No. 2094235-06-8, entered STN May 2, 2017. [cited by applicant]
CAS Registry No. 2094317-93-6, entered STN May 2, 2017. [cited by applicant]
CAS Registry No. 2094373-00-7, entered STN May 2, 2017. [cited by applicant]
CAS Registry No. 2094434-10-7, entered STN May 2, 2017. [cited by applicant]
CAS Registry No. 2094666-45-0, entered STN May 2, 2017. [cited by applicant]
CAS Registry No. 2094857-16-4, entered STN May 3, 2017. [cited by applicant]
CAS registry No. 2094888-54-5, entered STN May 3, 2017. [cited by applicant]
CAS registry No. 2138109-21-2, entered STN Nov. 2, 2017. [cited by applicant]
CAS registry No. 2138573-90-5, entered STN Nov. 6, 2017. [cited by applicant]
CAS Registry No. 2178688-56-5, entered STN Feb. 22, 2018. [cited by applicant]
CAS Registry No. 2189108-08-3, entered STN Mar. 12, 2018. [cited by applicant]
CAS Registry No. 2224022-18-6, entered STN May 20, 2018. [cited by applicant]
CAS Registry No. 2224161-16-8, entered STN May 20, 2018. [cited by applicant]
CAS Registry No. 891026-69-0, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891026-77-0, entered STN Jul. 9, 2006. [cited by applicant]
CAS registry No. 891027-33-1, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-11-1, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-19-9, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-57-9, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-65-9, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-73-9, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891027-89-7, entered STN Jul. 9, 2006. [cited by applicant]
CAS registry No. 891027-97-7, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891028-05-0, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891028-12-9, entered STN Jul. 9, 2006. [cited by applicant]
CAS Registry No. 891028-89-0, entered STN Jul. 9, 2006. [cited by applicant]
CAS registry No. 892699-07-9, entered STN Jul. 14, 2006. [cited by applicant]
CAS Registry No. 892699-21-7, entered STN Jul. 14, 2006. [cited by applicant]
CAS registry No. 892699-30-8, entered STN Jul. 14, 2006. [cited by applicant]
CAS Registry No. 892699-39-7, entered STN Jul. 14, 2006. [cited by applicant]
CAS registry No. 892699-67-1, entered STN Jul. 14, 2006. [cited by applicant]
Chavan et al., Indian Journal of Heterocyclic Chemistry, 2007, 17(1), 45-48. [cited by applicant]
Czudor et al., Bioorganic & Med. Chem. Let., 2018, vol. 28, p. 769-773. [cited by applicant]
Bruncko et al., “N-Acyl arenesulfonamides as apoptosis promoters and their preparation, pharmaceutical compositions and use in the treatment of diseases,” database CAPLUS Acc. No. 2007:359148, CAS SciFinder abstract of … [cited by applicant]
International Search Report and Written Opinion for PCT/EP2018/073431 dated Dec. 3, 2018, 9 pages. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Notice of Allowance dated Feb. 15, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Notice of Allowance dated May 23, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Notice of Allowance dated Sep. 7, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Request to Correct Inventorship filed Sep. 7, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Specification, claims, abstract filed Jun. 16, 2020. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Submission Under Rule 114 filed Aug. 23, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Submission Under Rule 114 with substitute specification filed May 14, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515 Updated Filing Receipt and Acceptance of Request to Correct Inventorship dated Sep. 12, 2022. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515, Nonfinal Office Action dated Oct. 1, 2021. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 16/902,515, Response filed Dec. 30, 2021. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 17/946,101, Preliminary Amendment with Substitute Specification filed Feb. 6, 2023. [cited by applicant]
Lagiakos et al., U.S. Appl. No. 17/946,101, Specification, claims, abstract filed Sep. 16, 2022. [cited by applicant]
Bozikis, U.S. Appl. No. 17/946,101, Non-Final Office Action dated Aug. 24, 2023, 12 pp. [cited by applicant]
Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US, compound with RN 1800260-63-2, retrieved from STN, entered Jul. 24, 2015. [cited by applicant]